Clinical Trials Logo

Exercise Performance clinical trials

View clinical trials related to Exercise Performance.

Filter by:

NCT ID: NCT04837898 Completed - Clinical trials for Exercise Performance

Haskap and Endurance Running Performance

Start date: April 12, 2021
Phase: N/A
Study type: Interventional

This study will employ a randomised, double-blind, placebo-controlled, independent groups experimental design. Submaximal, maximal and 5 km time trial running performance will be assessed before and after supplementation with haskap berry or a placebo.

NCT ID: NCT04293666 Completed - Fatigue Clinical Trials

Functional Evaluation of Kefir Drink on Antifatigue and Exercise Exercise Performance-2

Start date: January 27, 2019
Phase: N/A
Study type: Interventional

Purpose: The aim of the present study was to evaluate potential beneficial effects of Kefir drink (Synbio Tech Inc., Kaohsiung City, Taiwan) on fatigue and ergogenic functions following physiological challenge. Methods: 16 male subjects, 8 in each group, were divided into two groups according to the principle of maximal oxygen uptake, which were (1) first-stage placebo and second-stage Kefir group (hereinafter referred to as group A). (2) The first phase of Kefeier, the second phase of the placebo group (hereinafter referred to as group B), after 4 weeks of supplementation, the performance and fatigue resistance tests were carried out in sequence, including: treadmill aerobic endurance exhaustion time, and fixation Exercise time and intensity challenge changes in blood lactate, blood urea nitrogen concentration and creatine kinase activity, as well as differences in body composition before and after supplementation. After the first phase of the test is completed, the four weeks of emptying are performed. And after adding the crossover sample, perform four weeks of supplementation and testing again.

NCT ID: NCT04263246 Completed - Clinical trials for Exercise Performance

Medium-Term Supplementation With Herbal Extract for Exercise Performance and Antioxidant Status

PhytoDyNAmic
Start date: September 15, 2020
Phase: N/A
Study type: Interventional

We evaluated here the effects of 6-week intervention with herbal supplement on exercise performance outcomes and serum biomarkers of antioxidant status. In addition, we also assessed the long-term effects (6-month) of the intervention in elderly adults.

NCT ID: NCT04180787 Completed - Metabolism Clinical Trials

Effects of a Caffeine- and Protein-Containing Coffee Beverage on Metabolism and Muscular Performance

Start date: December 5, 2019
Phase: N/A
Study type: Interventional

The purpose of this randomized, double-blind, crossover study is to investigate the effects of Bang® Keto Coffee on resting and post-exercise metabolism and muscular performance during lower body resistance exercise.

NCT ID: NCT04004676 Recruiting - Ketosis Clinical Trials

Ketone Supplementation, Glycogen Replenishment and Time Trial Performance Following Glycogen Lowering Exercise

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

20 healthy trained males will volunteer to participate in this study. there will be 2 treatments: Carbohydrate- ketone supplementation and carbohydrate alone. The purpose of this study is to evaluate the effect of glucose-ketone supplementation on a 20 km cycling time trial with a 2-hour feeding during a 4-hour recovery period following glycogen depleting exercise.

NCT ID: NCT03977246 Completed - Clinical trials for Exercise Performance

Effect of Open-placebo Intervention on Cycling Performance

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effect of an open-label placebo intervention on cycling time-trial performance.

NCT ID: NCT03954665 Not yet recruiting - Ketosis Clinical Trials

Ketone Supplementation and Exercise Performance

Start date: September 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to observe the effects of exogenous ketone supplements during shorter bouts of exercise testing on twenty collegiate endurance trained athletes (18-25 years of age).

NCT ID: NCT03929575 Completed - Clinical trials for Exercise Performance

Effects of Herbal Supplements on Endurance Exercise Performance

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

Cordyceps and Rhodiola are two common herbal supplements marketed and consumed as adaptogens to athletes with regard to enhanced performance. The effects of these supplements has been well studied in animals but whether or not the same effects translate to humans is still unclear. Thus, the primary purpose of this study is to determine whether combined supplementation of Rhodiola and Cordyceps, compared to Rhodiola alone and placebo, will demonstrate a greater improvement in oxygen consumption (ie. VO2 max).

NCT ID: NCT03846141 Completed - Clinical trials for Exercise Performance

Hydrogen Inhalation for Health and Exercise Performance

HIHEP
Start date: January 15, 2018
Phase: N/A
Study type: Interventional

In this randomized double-blind, placebo-controlled, crossover pilot trial, we evaluated the effects of 7-day H2 inhalation on exercise performance outcomes and serum hormonal and inflammation profiles in a cohort of young men and women.

NCT ID: NCT03686982 Completed - Clinical trials for Exercise Performance

The Impact of Supplementation With Novel Prototype Nutrition Bar on Nitric Oxide Bioavailability and Measures of Athlete Performance

Start date: May 1, 2017
Phase: N/A
Study type: Interventional

Dietary nitrate, L-citrulline, epicatechin, vitamin C and glutathione have the potential to improve nitric oxide (NO) bioavailability, in humans, by influencing both the nitrate-nitrite-NO and NO synthase-dependent pathways, and the storage of NO. The study is designed to assess the efficacy of a newly developed product containing a mixture of these compounds. Specifically, the study will assess if the product is capable of increasing NO bioavailability and if this results in positive effects on exercise economy and intermittent exercise performance. These outcome measures have been chosen because they have previously been positively impacted by an increase in NO bioavailability.